Travel Grants 2019, France 2019-10-01 --02
|Funding from Vinnova||SEK 15 000|
|Project duration||September 2019 - October 2019|
Purpose and goal
Based on a unique method, RespiHeart aims at driving product development and CE certification in cooperation with established medtech and/or pharma actors. The purpose of the project has been to initiate contacts to enable the next step according to this strategy. In summary, the project has been successful and has met the objectives.
Expected results and effects
The company has got the opportunity to present its concept and strategy to investors as well as representatives for big pharma and French innovation hubs and networks. Further, a number of face-to-face meetings have been held with medtech participants and French life science startups. Follow-up and next step in relation to new contacts are currently ongoing.
Planned approach and implementation
RespiHeart´s CEO participated in the conference event "French-Swedish Life Science Days 2019", that was arranged by Business Sweden and partners on behalf of Vinnova, in Paris October 1-2 2019.